CONMED CORPORATION Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31)
CONMED CORPORATION (CNMD) reported Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) of $54.30 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-24.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount · last filed 2014-02-24
- CONMED CORPORATION stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for fiscal 2013 was $54.30M, a 48.24% decline from fiscal 2012.
- CONMED CORPORATION stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for fiscal 2012 was $104.90M, a 3.58% decline from fiscal 2011.
- CONMED CORPORATION stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for fiscal 2011 was $108.80M.
| Period end | Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 12 month |
|---|---|
| 2013-12-31 | $54.30M 10-K · filed 2014-02-24 |
| 2012-12-31 | $104.90M 10-K · filed 2013-02-25 |
| 2011-12-31 | $108.80M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |